Skip to main content
. 2016 Jan 4;17(9):1159–1172. doi: 10.1007/s10198-015-0752-3

Fig. 1.

Fig. 1

The selection process *Reviews, editorials, resource use and cost studies, as well as economic evaluations alongside a clinical trial were excluded at this step. CRT-D, cardiac resynchronization therapy device with the addition of an implantable cardioverter-defibrillator; HF, heart failure; NYHA, New York Heart Association functional classification; LVEF, left ventricular ejection fraction